Skip to main content
Log in

Overview

Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.

Via a program of reviews and original research articles, the journal is focused on linking diagnostic and prognostic biomarkers to appropriate therapy, with an emphasis on the development of companion diagnostic/therapeutic products, along with the analysis of pharmacogenomic data for drug development and therapeutic decision making.  

As a hybrid journal, Molecular Diagnosis & Therapy does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.

Molecular Drugs & Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Editor
  • Alison Fitches
Impact factor
4.0 (2022)
5 year impact factor
3.9 (2022)
Submission to first decision (median)
7 days
Downloads
253,056 (2023)

Latest articles

Journal updates

  • Digital Features

    Molecular Diagnosis & Therapy is able to host a range of digital features, with a number of options available to authors.

Journal information

Electronic ISSN
1179-2000
Print ISSN
1177-1062
Abstracted and indexed in
  1. Baidu
  2. CLOCKSS
  3. CNKI
  4. CNPIEC
  5. Chemical Abstracts Service (CAS)
  6. Current Contents/Life Sciences
  7. Dimensions
  8. EBSCO
  9. EMBASE
  10. EMBiology
  11. Google Scholar
  12. Japanese Science and Technology Agency (JST)
  13. Medline
  14. Meta
  15. Naver
  16. OCLC WorldCat Discovery Service
  17. Pathway Studio
  18. Portico
  19. ProQuest
  20. Reaxys
  21. SCImago
  22. SCOPUS
  23. Science Citation Index Expanded (SCIE)
  24. TD Net Discovery Service
  25. UGC-CARE List (India)
  26. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG

Navigation